These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 10830883)

  • 1. Redox reactions of neurotransmitters possibly involved in the progression of Parkinson's Disease.
    Linert W; Jameson GN
    J Inorg Biochem; 2000 Apr; 79(1-4):319-26. PubMed ID: 10830883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Casein phosphopeptide interferes the interactions between ferritin and ion irons.
    Sha X; Zhu L; Wu H; Li Y; Wu J; Zhang H; Zhang Y; Yang R
    Food Chem; 2024 Oct; 454():139752. PubMed ID: 38815330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Somatic transposition in the brain has the potential to influence the biosynthesis of metabolites involved in Parkinson's disease and schizophrenia.
    Abrusán G
    Biol Direct; 2012 Nov; 7():41. PubMed ID: 23176288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unscrambling the Role of Redox-Active Biometals in Dopaminergic Neuronal Death and Promising Metal Chelation-Based Therapy for Parkinson's Disease.
    Gonzalez-Alcocer A; Duarte-Jurado AP; Soto-Dominguez A; Loera-Arias MJ; Villarreal-Silva EE; Saucedo-Cardenas O; de Oca-Luna RM; Garcia-Garcia A; Rodriguez-Rocha H
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toxic Feedback Loop Involving Iron, Reactive Oxygen Species, α-Synuclein and Neuromelanin in Parkinson's Disease and Intervention with Turmeric.
    Jansen van Rensburg Z; Abrahams S; Bardien S; Kenyon C
    Mol Neurobiol; 2021 Nov; 58(11):5920-5936. PubMed ID: 34426907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knockout fth1b affects early mineralization of zebrafish pharyngeal teeth.
    Zhou CY; Zheng XD; Yang DQ
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2021 Feb; 39(1):32-37. PubMed ID: 33723934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biogenic Aldehyde-Mediated Mechanisms of Toxicity in Neurodegenerative Disease.
    Cagle BS; Crawford RA; Doorn JA
    Curr Opin Toxicol; 2019 Feb; 13():16-21. PubMed ID: 31304429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A review on iron chelators as potential therapeutic agents for the treatment of Alzheimer's and Parkinson's diseases.
    Singh YP; Pandey A; Vishwakarma S; Modi G
    Mol Divers; 2019 May; 23(2):509-526. PubMed ID: 30293116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Miniaturized FDDA and CMOS Based Potentiostat for Bio-Applications.
    Ghodsevali E; Morneau-Gamache S; Mathault J; Landari H; Boisselier É; Boukadoum M; Gosselin B; Miled A
    Sensors (Basel); 2017 Apr; 17(4):. PubMed ID: 28394289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of Protective Role of Multifunctional Dopamine Agonist D-512 Against Oxidative Stress Produced by Depletion of Glutathione in PC12 Cells: Implication in Neuroprotective Therapy for Parkinson's Disease.
    Voshavar C; Shah M; Xu L; Dutta AK
    Neurotox Res; 2015 Nov; 28(4):302-18. PubMed ID: 26201265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reactivity of catecholamine-driven Fenton reaction and its relationships with iron(III) speciation.
    Melin V; Henríquez A; Freer J; Contreras D
    Redox Rep; 2015 Mar; 20(2):89-96. PubMed ID: 25496478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The high-affinity D2/D3 agonist D512 protects PC12 cells from 6-OHDA-induced apoptotic cell death and rescues dopaminergic neurons in the MPTP mouse model of Parkinson's disease.
    Shah M; Rajagopalan S; Xu L; Voshavar C; Shurubor Y; Beal F; Andersen JK; Dutta AK
    J Neurochem; 2014 Oct; 131(1):74-85. PubMed ID: 24848702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. D-512 and D-440 as novel multifunctional dopamine agonists: characterization of neuroprotection properties and evaluation of in vivo efficacy in a Parkinson's disease animal model.
    Santra S; Xu L; Shah M; Johnson M; Dutta A
    ACS Chem Neurosci; 2013 Oct; 4(10):1382-92. PubMed ID: 23906010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of the Fe(III)-catalyzed dopamine oxidation by ATP and its relevance to oxidative stress in Parkinson's disease.
    Jiang D; Shi S; Zhang L; Liu L; Ding B; Zhao B; Yagnik G; Zhou F
    ACS Chem Neurosci; 2013 Sep; 4(9):1305-13. PubMed ID: 23823941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered transcription factor trafficking in oxidatively-stressed neuronal cells.
    Patel VP; Defranco DB; Chu CT
    Biochim Biophys Acta; 2012 Nov; 1822(11):1773-82. PubMed ID: 22902725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ferritin in adult-onset still's disease: just a useful innocent bystander?
    Mehta B; Efthimiou P
    Int J Inflam; 2012; 2012():298405. PubMed ID: 22536541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidative stress in schizophrenia.
    Bošković M; Vovk T; Kores Plesničar B; Grabnar I
    Curr Neuropharmacol; 2011 Jun; 9(2):301-12. PubMed ID: 22131939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ROS initiated oxidation of dopamine under oxidative stress conditions in aqueous and lipidic environments.
    Iuga C; Alvarez-Idaboy JR; Vivier-Bunge A
    J Phys Chem B; 2011 Oct; 115(42):12234-46. PubMed ID: 21919526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuclear transport, oxidative stress, and neurodegeneration.
    Patel VP; Chu CT
    Int J Clin Exp Pathol; 2011 Mar; 4(3):215-29. PubMed ID: 21487518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different mechanisms between copper and iron in catecholamines-mediated oxidative DNA damage and disruption of gene expression in vitro.
    Nishino Y; Ando M; Makino R; Ueda K; Okamoto Y; Kojima N
    Neurotox Res; 2011 Jul; 20(1):84-92. PubMed ID: 21053114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.